Skip to main content
ERJ Open logoLink to ERJ Open
letter
. 2023 Jun 15;61(6):2300484. doi: 10.1183/13993003.00484-2023

Implication of the Global Initiative for Chronic Obstructive Lung Disease 2023 report for resource-limited settings: tracing the G in the GOLD

Bruce J Kirenga 1,2,, Patricia Alupo 1, Frederik van Gemert 3, Rupert Jones 4
PMCID: PMC10269374  PMID: 37321612

The new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 report provides a very useful synthesis of available scientific evidence to guide COPD management, research and prevention, as always [1, 2]. Important changes include the revision of the definition of the condition and the replacement of groups C and D with E, which highlights the importance of exacerbations in COPD [2].

Short abstract

COPD guidelines still have blind spots for low-resource settings. If GOLD is truly to be considered a global report on COPD, more attention will need to be paid to practical solutions in global settings. https://bit.ly/3zusjOd


To the Editor:

The new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 report provides a very useful synthesis of available scientific evidence to guide COPD management, research and prevention, as always [1, 2]. Important changes include the revision of the definition of the condition and the replacement of groups C and D with E, which highlights the importance of exacerbations in COPD [2].

We reviewed the report to examine how well it addresses the issues surrounding COPD in Africa and other resource-limited settings. We commend the report for highlighting that COPD not related to cigarette smoking constitutes half of all COPD globally. In resource-limited settings, exposure to biomass smoke while cooking, outdoor air pollution and occupational exposure are the biggest drivers of COPD, especially among women. Pulmonary tuberculosis and HIV are also notable risk factors for COPD in this setting, with over 20% of COPD patients reporting having had a history of pulmonary tuberculosis [3].

In a study in rural Uganda, only 8% of women with COPD were current smokers, 84% had never smoked and >90% of people in the cohort had biomass exposure throughout their lives [4]. The report could have included more details on the importance of reducing or eliminating household air pollution exposure. Furthermore, the report points out the role of poverty-related exposures as another significant contributor to COPD in resource-limited settings. There are, however, other poverty-related factors associated with COPD in these settings, such as nutrition and infection, especially in early childhood. The report identifies childhood factors that impair lung growth and result in COPD in adulthood. Identified factors include prematurity, low birth weight, maternal smoking during pregnancy, repeated respiratory infections and poor nutrition, among others. We believe that household air pollution should be mentioned here as well. Young children (even before birth when a pregnant woman is cooking) are exposed to high levels of household air pollution, probably causing lifelong harm.

The report states that spirometry is needed to confirm the diagnosis of COPD, but spirometry is rarely available in Africa [5]. Given the prevalence of COPD, resources need to be made available to make the diagnosis. Screening questionnaires or peak expiratory flow testing are better than nothing. Our group used symptom and risk factor screening followed by peak expiratory flow testing and found it to be fairly accurate and feasible [6].

The report now recommends a combination of long-acting β-agonist (LABA) and long-acting muscarinic antagonist (LAMA) for all patients in groups B and E, with a possibility of adding inhaled corticosteroids to those with high peripheral blood eosinophils. Generally, inhaled medications are hard to access in most of Africa [7]. LAMA/LABAs are not widely available. Cheaper and more available alternatives should be included as alternatives in low-resource settings. However, other affordable interventions should be prominently promoted in resource-limited settings, including vaccinations for respiratory infections, pulmonary rehabilitation and surgical treatments.

In conclusion, the report is an excellent resource for understanding COPD and how best to manage it now. However, we agree with Tabyshova et al. [8] that COPD guidelines still have blind spots for low-resource settings. This matters, given most of the morbidity and more than 90% of COPD deaths occur in low-resource settings [9]. If this is truly to be considered a global report on COPD, more attention will need to be paid to practical solutions in global settings.

Shareable PDF

This one-page PDF can be shared freely online.

Shareable PDF ERJ-00484-2023.Shareable (224.6KB, pdf)

Footnotes

Conflict of interest: The authors have no potential conflicts of interest to declare.

References

  • 1.Agustí A, Celli BR, Criner GJ, et al. . Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J 2023; 61: 2300239. doi: 10.1183/13993003.00239-2023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Adeloye D, Chan KY, Rudan I, et al. . An estimate of asthma prevalence in Africa: a systematic analysis. Croat Med J 2013; 54: 519–531. doi: 10.3325/cmj.2013.54.519 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Alupo P, Wosu AC, Mahofa A, et al. . Incidence and predictors of COPD mortality in Uganda: a 2-year prospective cohort study. PLoS One 2021; 16: e0246850. doi: 10.1371/journal.pone.0246850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.van Gemert F, Kirenga B, Chavannes N, et al. . Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. Lancet Glob Health 2015; 3: e44–e51. doi: 10.1016/S2214-109X(14)70337-7 [DOI] [PubMed] [Google Scholar]
  • 5.Kibirige D, Kampiire L, Atuhe D, et al. . Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective. BMC Pulm Med 2017; 17: 179. doi: 10.1186/s12890-017-0527-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Siddharthan T, Pollard SL, Quaderi SA, et al. . Discriminative accuracy of chronic obstructive pulmonary disease screening instruments in 3 low- and middle-income country settings. JAMA 2022; 327: 151–160. doi: 10.1001/jama.2021.23065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kibirige D, Sanya RE, Nantanda R, et al. . Availability and affordability of medicines and diagnostic tests recommended for management of asthma and chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review. Allergy Asthma Clin Immunol 2019; 15: 14. doi: 10.1186/s13223-019-0329-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tabyshova A, Hurst JR, Soriano JB, et al. . Gaps in COPD guidelines of low- and middle-income countries: a systematic scoping review. Chest 2021; 159: 575–584. doi: 10.1016/j.chest.2020.09.260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.GBD 2015 Chronic Respiratory Disease Collaborators . Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 2017; 5: 691–706. doi: 10.1016/S2213-2600(17)30293-X [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

This one-page PDF can be shared freely online.

Shareable PDF ERJ-00484-2023.Shareable (224.6KB, pdf)


Articles from The European Respiratory Journal are provided here courtesy of European Respiratory Society

RESOURCES